21. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY. Issue 2 (February 2021) Authors: Leonardi, Sergio; Branca, Mattia; Franzone, Anna; McFadden, Eugene; Piccolo, Raffaele; Jüni, Peter; Vranckx, Pascal; Steg, Philippe Gabriel; Serruys, Patrick W.; Benit, Edouard; Liebetrau, Christoph; Janssens, Luc; Ferrario, Maurizio; Zurakowski, Aleksander; Diletti, Roberto; Dominici, Marcello; ... Journal: Circulation Issue: Volume 14:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy. (10th June 2021) Authors: Collet, Jean-Philippe; Thiele, Holger; Giannitsis, Evangelos; Sibbing, Dirk; Barthélémy, Olivier; Bauersachs, Johann; Bhatt, Deepak L; Dendale, Paul; Dorobantu, Maria; Edvardsen, Thor; Folliguet, Thierry; Gale, Chris P; Gilard, Martine; Jobs, Alexander; Jüni, Peter; Lambrinou, Ekaterini; Lewis, B... Journal: European heart journal Issue: Volume 42:Number 31(2021) Page Start: 2973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Issue 19 (21st July 2012) Authors: Vranckx, Pascal; Farooq, Vasim; Garg, Scot; Van Es, Gerrit-Anne; Silber, Sigmund; Windecker, Stephan; Stone, Gregg W; Serruys, Patrick W Journal: Heart Issue: Volume 98:Issue 19(2012) Page Start: 1424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial. (1st July 2015) Authors: Adamo, Marianna; Costa, Francesco; Vranckx, Pascal; Leonardi, Sergio; Navarese, Eliano P.; Garcia-Garcia, Hector M.; Valgimigli, Marco Journal: International journal of cardiology Issue: Volume 190(2015) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. (7th December 2022) Authors: Costa, Francesco; Montalto, Claudio; Branca, Mattia; Hong, Sung-Jin; Watanabe, Hirotoshi; Franzone, Anna; Vranckx, Pascal; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Feres, Fausto; Jang, Yangsoo; De Luca, Giuseppe; Kedhi, Elvin; Cao, Davide; Steg, Philippe Gabriel; Bhatt, Deepak L; Stone, Gregg W; Micari... Journal: European heart journal Issue: Volume 44:Number 11(2023) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. Issue 3 (25th November 2022) Authors: Montalto, Claudio; Costa, Francesco; Leonardi, Sergio; Micari, Antonio; Oreglia, Jacopo A; Vranckx, Pascal; Capodanno, Davide; ten Berg, Jurriën; Lopes, Renato D; Valgimigli, Marco Journal: European heart journal Issue: Volume 9:Issue 3(2023) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis . (22nd June 2022) Authors: Valgimigli, Marco; Smits, Pieter C; Frigoli, Enrico; Bongiovanni, Dario; Tijssen, Jan; Hovasse, Thomas; Mafragi, Al; Ruifrok, Willem Theodoor; Karageorgiev, Dimitar; Aminian, Adel; Garducci, Stefano; Merkely, Bela; Routledge, Helen; Ando, Kenji; Diaz Fernandez, Josè Francisco; Cuisset, Thomas; Ne... Journal: European heart journal Issue: Volume 43:Number 33(2022) Page Start: 3100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Dyspnoea in the GLOBAL LEADERS trial – Authors' reply. Issue 10189 (15th June 2019) Authors: Jüni, Peter; Vranckx, Pascal; Valgimgli, Marco; Serruys, Patrick; Windecker, Stephan Journal: Lancet Issue: Volume 393:Issue 10189(2019) Page Start: 2393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial. (29th August 2020) Authors: Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Lewalter, Thorsten; Unikas, Ramunas; Marin, Francisco; Schiele, François; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Tijssen, Jan; Goette, Andreas Journal: European heart journal Issue: Volume 41:Number 47(2020) Page Start: 4497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Issue 10206 (12th October 2019) Authors: Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Tijssen, Jan; Lewalter, Thorsten; Gargiulo, Giuseppe; Batushkin, Valerii; Campo, Gianluca; Lysak, Zoreslava; Vakaliuk, Igor; Milewski, Krzysztof; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Goette, Andreas Journal: Lancet Issue: Volume 394:Issue 10206(2019) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗